These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring. Halaby CA; Young SP; Austin S; Stefanescu E; Bali D; Clinton LK; Smith B; Pendyal S; Upadia J; Schooler GR; Mavis AM; Kishnani PS Genet Med; 2019 Dec; 21(12):2686-2694. PubMed ID: 31263214 [TBL] [Abstract][Full Text] [Related]
8. Dietary management in glycogen storage disease type III: what is the evidence? Derks TG; Smit GP J Inherit Metab Dis; 2015 May; 38(3):545-50. PubMed ID: 25164784 [TBL] [Abstract][Full Text] [Related]
9. Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature. Massimino E; Amoroso AP; Lupoli R; Rossi A; Capaldo B Front Nutr; 2023; 10():1178348. PubMed ID: 37252245 [TBL] [Abstract][Full Text] [Related]
10. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Coleman RA; Winter HS; Wolf B; Gilchrist JM; Chen YT Ann Intern Med; 1992 Jun; 116(11):896-900. PubMed ID: 1580445 [TBL] [Abstract][Full Text] [Related]
11. Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III. Jauze L; Monteillet L; Mithieux G; Rajas F; Ronzitti G Hum Gene Ther; 2019 Oct; 30(10):1263-1273. PubMed ID: 31319709 [TBL] [Abstract][Full Text] [Related]
12. Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice. Pagliarani S; Lucchiari S; Ulzi G; Ripolone M; Violano R; Fortunato F; Bordoni A; Corti S; Moggio M; Bresolin N; Comi GP Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3407-3417. PubMed ID: 30076962 [TBL] [Abstract][Full Text] [Related]
14. Modified Atkins ketogenic diet improves heart and skeletal muscle function in glycogen storage disease type III. Francini-Pesenti F; Tresso S; Vitturi N Acta Myol; 2019 Mar; 38(1):17-20. PubMed ID: 31309177 [TBL] [Abstract][Full Text] [Related]
15. Beneficial Effects of Modified Atkins Diet in Glycogen Storage Disease Type IIIa. Olgac A; İnci A; Okur İ; Biberoğlu G; Oğuz D; Ezgü FS; Kasapkara ÇS; Aktaş E; Tümer L Ann Nutr Metab; 2020; 76(4):233-241. PubMed ID: 32712609 [TBL] [Abstract][Full Text] [Related]
16. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? Demo E; Frush D; Gottfried M; Koepke J; Boney A; Bali D; Chen YT; Kishnani PS J Hepatol; 2007 Mar; 46(3):492-8. PubMed ID: 17196294 [TBL] [Abstract][Full Text] [Related]
17. Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions. Derks TG; van Rijn M J Inherit Metab Dis; 2015 May; 38(3):537-43. PubMed ID: 25633903 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature. Beyzaei Z; Geramizadeh B; Karimzadeh S Orphanet J Rare Dis; 2020 Oct; 15(1):286. PubMed ID: 33054851 [TBL] [Abstract][Full Text] [Related]
19. Cardiac involvement in glycogen storage disease type III. Moses SW; Wanderman KL; Myroz A; Frydman M Eur J Pediatr; 1989 Aug; 148(8):764-6. PubMed ID: 2792130 [TBL] [Abstract][Full Text] [Related]
20. Diet and growth of children with glycogen storage disease Types I and III. Daeschel IE; Janick LS; Kramish MJ; Coleman RA J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]